Guillain-Barre Syndrome - Pipeline Review, H2 2015

Publisher Name :
Date: 09-Dec-2015
No. of pages: 46
Inquire Before Buying
Offers on Market Research Reports at RnRMarketResearch.com

Global Markets Direct's, ‘Guillain-Barre Syndrome - Pipeline Review, H2 2015', provides an overview of the Guillain-Barre Syndrome's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Guillain-Barre Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Guillain-Barre Syndrome and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Guillain-Barre Syndrome

  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

  • The report reviews key players involved in the therapeutics development for Guillain-Barre Syndrome and enlists all their major and minor projects

  • The report summarizes all the dormant and discontinued pipeline projects

  • A review of the Guillain-Barre Syndrome products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

  • A detailed assessment of monotherapy and combination therapy pipeline projects

  • Coverage of the Guillain-Barre Syndrome pipeline on the basis of target, MoA, route of administration and molecule type

  • Latest news and deals relating related to pipeline products

Reasons to buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Develop strategic initiatives by understanding the focus areas of leading companies

  • Identify and understand important and diverse types of therapeutics under development for Guillain-Barre Syndrome

  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

  • Devise corrective measures for pipeline projects by understanding Guillain-Barre Syndrome pipeline depth and focus of Indication therapeutics

  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Guillain-Barre Syndrome - Pipeline Review, H2 2015

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Guillain-Barre Syndrome Overview 6
Therapeutics Development 7
Pipeline Products for Guillain-Barre Syndrome - Overview 7
Pipeline Products for Guillain-Barre Syndrome - Comparative Analysis 8
Guillain-Barre Syndrome - Therapeutics under Development by Companies 9
Guillain-Barre Syndrome - Therapeutics under Investigation by Universities/Institutes 10
Guillain-Barre Syndrome - Pipeline Products Glance 11
Late Stage Products 11
Clinical Stage Products 12
Early Stage Products 13
Guillain-Barre Syndrome - Products under Development by Companies 14
Guillain-Barre Syndrome - Products under Investigation by Universities/Institutes 15
Guillain-Barre Syndrome - Companies Involved in Therapeutics Development 16
Akari Therapeutics, Plc 16
Alexion Pharmaceuticals, Inc. 17
Takeda Pharmaceutical Company Limited 18
Guillain-Barre Syndrome - Therapeutics Assessment 19
Assessment by Monotherapy Products 19
Assessment by Target 20
Assessment by Mechanism of Action 22
Assessment by Route of Administration 24
Assessment by Molecule Type 26
Drug Profiles 28
Coversin - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
eculizumab - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
immune globulin (human) - Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
immune globulin (human) - Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Peptide for Cholera and Guillain-Barre Syndrome - Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
Guillain-Barre Syndrome - Recent Pipeline Updates 37
Guillain-Barre Syndrome - Dormant Projects 44
Appendix 45
Methodology 45
Coverage 45
Secondary Research 45
Primary Research 45
Expert Panel Validation 45
Contact Us 45
Disclaimer 46

List of Tables

Number of Products under Development for Guillain-Barre Syndrome, H2 2015 7
Number of Products under Development for Guillain-Barre Syndrome - Comparative Analysis, H2 2015 8
Number of Products under Development by Companies, H2 2015 9
Number of Products under Investigation by Universities/Institutes, H2 2015 10
Comparative Analysis by Late Stage Development, H2 2015 11
Comparative Analysis by Clinical Stage Development, H2 2015 12
Comparative Analysis by Early Stage Development, H2 2015 13
Products under Development by Companies, H2 2015 14
Products under Investigation by Universities/Institutes, H2 2015 15
Guillain-Barre Syndrome - Pipeline by Akari Therapeutics, Plc, H2 2015 16
Guillain-Barre Syndrome - Pipeline by Alexion Pharmaceuticals, Inc., H2 2015 17
Guillain-Barre Syndrome - Pipeline by Takeda Pharmaceutical Company Limited, H2 2015 18
Assessment by Monotherapy Products, H2 2015 19
Number of Products by Stage and Target, H2 2015 21
Number of Products by Stage and Mechanism of Action, H2 2015 23
Number of Products by Stage and Route of Administration, H2 2015 25
Number of Products by Stage and Molecule Type, H2 2015 27
Guillain-Barre Syndrome Therapeutics - Recent Pipeline Updates, H2 2015 37
Guillain-Barre Syndrome - Dormant Projects, H2 2015 44

List of Figures

Number of Products under Development for Guillain-Barre Syndrome, H2 2015 7
Number of Products under Development for Guillain-Barre Syndrome - Comparative Analysis, H2 2015 8
Number of Products under Development by Companies, H2 2015 9
Number of Products under Investigation by Universities/Institutes, H2 2015 10
Comparative Analysis by Late Stage Development, H2 2015 11
Comparative Analysis by Early Stage Products, H2 2015 13
Assessment by Monotherapy Products, H2 2015 19
Number of Products by Targets, H2 2015 20
Number of Products by Stage and Targets, H2 2015 20
Number of Products by Mechanism of Actions, H2 2015 22
Number of Products by Stage and Mechanism of Actions, H2 2015 22
Number of Products by Routes of Administration, H2 2015 24
Number of Products by Stage and Routes of Administration, H2 2015 24
Number of Products by Molecule Types, H2 2015 26
Number of Products by Stage and Molecule Types, H2 2015 26
  • Global Public Safety LTE Ecosystem Overview
    In view of its flourishing ecosystem, spectrum flexibility and performance metrics, LTE has emerged as the leading candidate for public safety mobile broadband networks. Public safety organizations and establishments have already begun planning to advance their networks to LTE-based public safety solutions. LTE provisions a varied range of services, from high bandwidth data services to [...]
  • RnR Market Research: Biochips Market Insights
    Growing R&D investment and subcontracting of pharmaceutical companies would lead to growth in biochips market in Asia along with an increase in the application of biochips products is estimated to improve opportunity for the global biochip market. Conversely, the high cost involved in manufacturing of biochips can be seen as a challenge for the same. [...]
  • Current State of Blood Banking Market, Products, Technologies and Services
    The global blood banking and blood products market is expected to reach US$41.9 billion by 2020 with USA continuing to be the largest market worldwide. Asia-Pacific follows a close second with a projected CAGR of 9.1% during this period owing to the refining healthcare infrastructure and increase in the per capita healthcare expenditure. The major [...]
  • Surgical Robots Market 2016 Updates on Companies, Products and More
    Surgical robots are medical devices that assist surgeons in performing many types of complex procedures with more accuracy, flexibility and control than is possible with conventional techniques. The aim of surgical robots market players is to provide improved diagnostic skills, a less invasive and more comfortable experience for the patient, and the ability to do [...]
  • International Wound Cleanser Industry 2019 Forecasts with Feasibility Study of Future Projects
    ‘Market Research Report on Global and Chinese Wound Cleanser Industry, 2009-2019’ is a comprehensive market research report that offers top-notch industry insights and analyzes the growth prospects of the industry, along with evaluating the up-surging opportunities in the Global and Chinese market over the forecast period of 2014-2019. The methodically planned sections of the research [...]
  • Global Spinal Cord Partnering 2010 to 2016
    Published: 01-Jun-2016        Price: US 1495 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." Summary Provides understanding and access to the spinal cord partnering deals and agreements entered into by the worlds leading healthcare companies . Description The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trend......
  • Global Neuropathy Partnering 2010 to 2016
    Published: 01-Jun-2016        Price: US 1495 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." Summary Provides understanding and access to the neuropathy partnering deals and agreements entered into by the worlds leading healthcare companies. Description The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends ......
  • Spinal Cord Injury - Pipeline Review, H1 2016
    Published: 25-May-2016        Price: US 2000 Onwards        Pages: 228
    Global Markets Direct's, ‘Spinal Cord Injury - Pipeline Review, H1 2016', provides an overview of the Spinal Cord Injury pipeline landscape. The report provides comprehensive information on the therapeutics under development for Spinal Cord Injury, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete res......
  • Brain Ischemia - Pipeline Review, H1 2016
    Published: 27-Apr-2016        Price: US 2000 Onwards        Pages: 64
    Global Markets Direct's, ‘Brain Ischemia - Pipeline Review, H1 2016', provides an overview of the Brain Ischemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Brain Ischemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and de......
  • Friedreich Ataxia - Pipeline Review, H1 2016
    Published: 13-Apr-2016        Price: US 2000 Onwards        Pages: 91
    Global Markets Direct's, ‘Friedreich Ataxia - Pipeline Review, H1 2016', provides an overview of the Friedreich Ataxia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Friedreich Ataxia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete resear......
  • Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H1 2016
    Published: 30-Mar-2016        Price: US 2000 Onwards        Pages: 86
    Global Markets Direct's, ‘Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H1 2016', provides an overview of the Neuromyelitis Optica (Devic's Syndrome) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Neuromyelitis Optica (Devic's Syndrome), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descripti......
  • Nerve Injury - Pipeline Review, H1 2016
    Published: 24-Feb-2016        Price: US 2000 Onwards        Pages: 73
    Global Markets Direct's, ‘Nerve Injury - Pipeline Review, H1 2016', provides an overview of the Nerve Injury pipeline landscape. The report provides comprehensive information on the therapeutics under development for Nerve Injury, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and developm......
  • Herpes Simplex Encephalitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
    Published: 01-Jan-2016        Price: US 2000 Onwards        Pages: 100
    Summary DelveInsight's Report, "Herpes Simplex Encephalitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Herpes Simplex Encephalitis Report is to understand the market and pipeline status of the drugs around the Herpes Simplex Encephalitis to explore the gene......
  • Acute Spinal Cord Injury-Pipeline Insights, 2016
    Published: 01-Jan-2016        Price: US 1250 Onwards        Pages: 60
    SUMMARY DelveInsight's, " Acute Spinal Cord Injury-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Acute Spinal Cord Injury. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, lice......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs